erlotinib hydrochloride has been researched along with Canine Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, S | 1 |
| Mantovani, FB; Morrison, JA; Mutsaers, AJ | 1 |
2 other study(ies) available for erlotinib hydrochloride and Canine Diseases
| Article | Year |
|---|---|
Presumed erlotinib-induced bilateral corneal ulcers in a dog with lung tumor.
Topics: Animals; Cornea; Corneal Ulcer; Dog Diseases; Dogs; Erlotinib Hydrochloride; Lung Neoplasms; Male; Tears | 2023 |
Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Dog Diseases; Dogs; ErbB Receptors; Erlotinib Hydrochloride; Osteosarcoma; Protein Kinase Inhibitors; Radiation Tolerance; Vascular Endothelial Growth Factor A | 2016 |